Page 78 - IJB-9-3
P. 78

International Journal of Bioprinting                        3DP hydrogels to combat antibiotic-resistant bacteria























            Figure 2. Scanning electron microscopy images and size distribution histograms of (a) non-loaded (control; C-NPs), (b) Rif- and (c) Van-loaded LMW
            PLGA NPs (n = 250).

            Table 1. Mean size ± standard deviation, PDI, encapsulation efficiency, and drug loading of non-loaded (control; C-NPs) and Van-
            (Van-NPs) or Rif-loaded PLGA NPs (Rif-NPs)

             Drug loading           Molecular weight  Mean size (nm)  PDI    Encapsulation efficiency (%)  DL (mg/mg)
             Non-loaded (control)   LMW             228 ± 124    0.29
             Rif                    LMW             164 ± 67     0.17       21.10                  68.86
             Rif                    MMW             257 ± 83     0.10       20.27                  29.80
             Rif                    HMW             293 ± 76     0.07       12.41                  16.60
             Van                    LMW             207 ± 64     0.10       53.40                  59.98
             Van                    MMW             277 ± 81     0.09       36.60                  40.61
             Van                    HMW             253 ± 78     0.10       60.00                  68.53
            HMW, high molecular weight; LMH, low molecular weight; MMW, medium molecular weight.
            3.2. GelMA and GelMA-PLGA NPs hydrogel             in the swelling properties was observed when reducing
            characterization                                   the GelMA concentration. No differences in swelling
            The degree of functionalization (DoF) of GelMA hydrogel   properties  were  observed  when  loading  PLGA  NPs  into
            was measured by quantifying the amount of the non-  the GelMA hydrogels (Figure S3c).
            reacted amine groups after the chemical modification. The
            obtained results showed a DoF of 87.9%.            3.3. 3D-printed antimicrobial hydrogels
                                                               GelMA-C-NPs, GelMA-Rif-NPs, GelMA-Van-NPs, and
               Dynamic shear rheometer analysis was performed to
            study the physical crosslinking of GelMA and GelMA-C-  GelMA-Rif-Van-NPs were successfully 3D-printed in a total
                                                               of 4 alternating layers at 0 and 90 degrees, with a 500-µm
            NPs hydrogels from 5°C to 40°C. This analysis provided   distance between fibers within each layer (Figure 4a–c). The
            quantitative information about the viscoelastic properties of   hydrogels containing the combination of GelMA-Rif-NPs
            the polymer under periodic rotational strain deformation.   and GelMA-Van-NPs (GelMA-Rif-Van-NPs) were printed
            The viscosity, the loss modulus (Gʹ), and the storage modulus   with the same printing parameters and intercalating layers
            (G˝) were evaluated. The sol–gel temperature increased   of two different inks within four layers (Rif-Van-Rif-Van)
            while the polymer concentration increasing (Figure S2),   (Figure 4c, f–i, Table 2).
            and no significant differences were observed in the sol–
            gel temperature of GelMA compared to GelMA-C-NPs   3.4. In vitro drug release
            (Figure 3a and b). The best fiber formation and printability   The  cumulative  drug  release  of  Rif-NPs  and  Van-NPs
            was obtained when the printing-head temperature was set   (LMW, MMW, and HMW) is shown in Figure 5. A strong
            at 27°C (1°C–2°C below the sol–gel temperature).
                                                               dependency on the molecular weight of the PLGA was
               The compression test showed no significant differences   observed. For the Rif-NPs with LMW and MMW PLGA
            in the Young’s modulus of GelMA-C-NPs compared to   and the Van-NPs with LMW PLGA, a biphasic release was
            GelMA without NPs (Figure S3a  and  b). An increase   observed, with an initial burst release followed by a sustained


            Volume 9 Issue 3 (2023)                         70                         https://doi.org/10.18063/ijb.683
   73   74   75   76   77   78   79   80   81   82   83